HTLV-I and HTLV-II are oncogenic retroviruses associated with neoplastic transformation of CD4+ and CD8+ T-lymphocytes. These viruses display distinct pathogenic properties in vivo; however, both viruses infect and transform primary human T-cells in cell culture. The viral trans-activator protein, Tax, has been implicated in the HTLV oncogenic process, primarily due to its ability to aberrantly activate T-cell genes involved in growth regulation. However, conclusive evidence for the role of Tax in the induction of malignancy is lacking because of the inability to mutate tax in the context of an infectious virus in order to dissociate viral replication from cellular transformation. To circumvent this problem, a mutant HTLV-II (HTLV C-enh), which replicates by a Tax independent mechanism, was constructed. This unique chimeric virus maintains the capacity to efficiently transform primary T-cells; however, a replication-competent tax-knockout of this virus fails to transform T-cells indicating that Tax is required for T-cell transformation by HTLV. Domains of Tax important for HTLV-mediated transformation of human T-cells have not been identified nor has the physiological role of phosphorylation in Tax function been ascertained. The novel HTLV- c-enh provides a unique opportunity to study Tax flinction in an infectious virus system. Three integrated specific aims are proposed to precisely determine the molecular basis of T-cell transformation, T-cell tropism, and induction of leukemia by HTLV.
In Specific Aim 1, a functional analysis of HTLV-II-tax will identify mutants that fail to transactivate CREB/ATF or NFkappaB/Rel signaling pathways, hypothesized to be important for transformation, and determine the functional significance of Tax phosphorylation.
In Specific Aim 2, HTLV C-enh mutant viruses will be used to determine the precise mechanism by which Tax mediates transformation of human T- cells. An HTLV-I that replicates by a Tax-independent mechanism will be generated for comparative studies.
In Specific Aim 3, the molecular basis for pathogenic differences between HTLV-I and HTLV-II, with specific emphasis on CD4+ and CD8+ T-cell transformation tropism, will be determined using HTLV-I/HTLV-II recombinants and transformation assays. The proposed experiments will provide fundamental information about functional determinants of HTLV-II Tax, on HTLV-I and HTLV-II biology, and the mechanism of HTLV transformation and pathogenesis. Moreover, these studies will contribute to a better understanding of T-cell activation and differentiation. This information may be critical for future therapeutic approaches for cancers associated with these viruses as well as other types of T-cell leukemias and lymphomas.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA077556-02
Application #
2733425
Study Section
Virology Study Section (VR)
Program Officer
Cole, John S
Project Start
1997-09-15
Project End
2002-06-30
Budget Start
1998-07-01
Budget End
1999-06-30
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Ohio State University
Department
Veterinary Sciences
Type
Schools of Veterinary Medicine
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Kannian, Priya; Fernandez, Soledad; Jones, Kathryn S et al. (2013) Human T lymphotropic virus type 1 SU residue 195 plays a role in determining the preferential CD4+ T cell immortalization/transformation tropism. J Virol 87:9344-52
Kannian, Priya; Yin, Han; Doueiri, Rami et al. (2012) Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion. J Virol 86:3757-66
Satou, Yorifumi; Yasunaga, Jun-Ichirou; Zhao, Tiejun et al. (2011) HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog 7:e1001274
Zhao, Tiejun; Satou, Yorifumi; Sugata, Kenji et al. (2011) HTLV-1 bZIP factor enhances TGF-? signaling through p300 coactivator. Blood 118:1865-76
Jones, Kathryn S; Green, Patrick L (2010) Cloaked virus slips between cells. Nat Med 16:25-7
Li, Min; Kesic, Matthew; Yin, Han et al. (2009) Kinetic analysis of human T-cell leukemia virus type 1 gene expression in cell culture and infected animals. J Virol 83:3788-97
Matsuoka, Masao; Green, Patrick L (2009) The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology 6:71
Li, Min; Green, Patrick L (2007) Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR. J Virol Methods 142:159-68
Ishioka, Kojiro; Higuchi, Masaya; Takahashi, Masahiko et al. (2006) Inactivation of tumor suppressor Dlg1 augments transformation of a T-cell line induced by human T-cell leukemia virus type 1 Tax protein. Retrovirology 3:71
Niinuma, Akiko; Higuchi, Masaya; Takahashi, Masahiko et al. (2005) Aberrant activation of the interleukin-2 autocrine loop through the nuclear factor of activated T cells by nonleukemogenic human T-cell leukemia virus type 2 but not by leukemogenic type 1 virus. J Virol 79:11925-34

Showing the most recent 10 out of 17 publications